B. Braun is one of the world's leading companies in international healthcare. The B. Braun OEM Division offers a wide range of products and services for the pharmaceutical and medical device industry.The product portfolio comprises pharmaceutical solutions, medical devices and
is a world leader in excipients, with innovative products, patented technologies and technical expertise for pharmaceutical and nutritional industries worldwide.JRS Pharma offers the most complete portfolio of high quality, high functionality excipients and technologies, especially for solid dosage forms. Our
Transave's ARIKACE may have the ability to penetrate mucus and biofilms, and decrease the number of Pseudomonas aeruginosa lung infections in patients with cystic fibrosis.
The Advocacy Project will aim to increase awareness and appreciation of the value of immunization in fifteen countries that are receiving time-limited support from the Global Alliance for Vaccines and Immunization (GAVI), leading to increased government and external contributions and,
The "USP Chapter 797: Understanding the Revisions" technical paper, authored by Baxa Corporation's Mike Hurst, RPh, MBA, is now accessible at Expert411.com for media and professional reference. USP Chapter 797 became official on January 1, 2004 The first major revision
LegalView updated its Baxter Heparin information portal to add information on the most recent recall of the blood-thinning drug. Heparin, which is used to control blood during surgical procedures, was recently discovered to have a Heparin-like contaminant that sickened many
Now, "one call does it all" speeding the process of procuring needed prescription medications and medical supplies for Passages Hospice patients and their families across Illinois, around-the-clock and seven days a week, through a contract with Jewel-Osco, part of SUPERVALU,
TrialStat Corporation, the industry's first clinical data solutions on demand company, today continued to shape discussion around adaptive clinical trials by participating in the E-Clinical Trials conference in Montreal. (PRWeb Mar 31, 2008) Read the full story at http://ww1.prweb.com/releases/2008/03/prweb812294.htm
Dr. Roger Kenneth Hershline PhD MD, the CEO of Global Humanceuticals, Inc and founder and chairman of the not-for-profit public charity CureHIV.us, announces today that he is reaching out to Bill and Melinda Gates for funding from their Grand Challenges
AxFlow through its Aberdeen group has been expanding its reputation and business in the North Sea oil and gas industry, winning orders for pump systems to be used on a Produced Water Package (PWP). (PRWeb Apr 1, 2008) Read the
Michel Detheux, Ph.D., Director Euroscreen FAST Business Unit ,will present Euroscreen FAST capabilities and expertise at the 14th Annual Conference and Exhibition of the Society for Biomolecular Sciences (SBS Meeting) in St. Louis. (PRWeb Apr 1, 2008) Read the full
Biopharmaceutical firm Medarex has announced that it will receive a milestone payment for an undisclosed amount from its licensing partner, Novo Nordisk.
NeoVista has announced positive results from a one-year feasibility study of the company's novel epiretinal brachytherapy for the wet form of age-related macular degeneration.
Pharming Group has announced that it's wholly owned subsidiary DNage will head a collaborative R&D effort to identify novel biomarkers and therapeutic targets, and to develop therapeutics for the treatment of premature ageing diseases.
New York-Presbyterian Hospital/Weill Cornell Medical Center has announced that it is recruiting patients for a national clinical research study of an investigational implantable device designed to help those with type-2 diabetes, who are overweight and do not respond to current
QLT has announced that results from a Phase II study, in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration, showed that a combination therapy of Visudyne followed by bevacizumab reduced, by half, the number of treatments required during
